BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 2nd Quarter - Termination

FIGHT COLORECTAL CANCER

via MS. MARGARET CARVIN

2nd Quarter (Apr 1 - June 30) · 2017Posted Jun 19, 2017Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: FIGHT COLORECTAL CANCER
Description: Promotes screening of individuals for colorectal cancer, funding for research
Location: Missouri · United States of America

Registrant

Firm: MS. MARGARET CARVIN
Description: work on issues for Fight Colorectal Cancer funding, prevention, and research
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Accounting
Accountable Care Act, Appropriations for NIH, NCI, DoD, CDC. The Removing Barriers to Colorectal Cancer Screening Act.
LobbyistsMARGARET CARVIN
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

FIGHT COLORECTAL CANCER — Lobbying — Receipts Report